EUVIMEDEUVIMED entdecken
Leserbrief

Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

Marc Miravitlles iD, Alice M Turner iD, María Torres-Duran, Hanan Tanash, Carlota Rodríguez-García, José Luis López-Campos iD, Jan Chlumsky iD, Catarina Guimaraes, Juan Luis Rodríguez-Hermosa, Angelo Corsico, Cristina Martinez-González, José María Hernández-Pérez iD und 12 weitere

European Respiratory Journal · 2023-03 · 61 (3) · 2201949

DOI: 10.1183/13993003.01949-2022 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 30.03.2023. Verfasst von Marc Miravitlles und 23 weiteren Autor:innen. Beteiligte Einrichtung: Pneumology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain marcm@separ.es. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: European Respiratory Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha 1-Antitrypsin DeficiencyHumansalpha 1-AntitrypsinRegistriesPhenotype

Substanzen

alpha 1-Antitrypsin

Autor:innen und Institutionen

  • Pneumology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain marcm@separ.es.
  • Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Servicio de Neumología, Hospital Álvaro Cunqueiro, NeumoVigo I+i Research Group, IIS Galicia Sur, Vigo, Spain.

ORCID-Profile: Marc Miravitlles, Alice M Turner, José Luis López-Campos, Jan Chlumsky, José María Hernández-Pérez, Ana Bustamante, David G Parr, Wim Janssens, Beatriz Lara, Cruz González, Christian F Clarenbach

Förderung

  • European Respiratory Society

Zitieren

APA

Miravitlles, M., Turner, A. M., Torres-Duran, M., Tanash, H., Rodríguez-García, C., López-Campos, J. L., Chlumsky, J., Guimaraes, C., Rodríguez-Hermosa, J. L., Corsico, A., Martinez-González, C., Hernández-Pérez, J. M., Bustamante, A., Parr, D. G., Casas-Maldonado, F., Hecimovic, A., Janssens, W., Lara, B., Barrecheguren, M., …, & EARCO study investigators (2023). Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry. European Respiratory Journal, 61(3), 2201949. https://doi.org/10.1183/13993003.01949-2022

Vancouver

Miravitlles M, Turner AM, Torres-Duran M, Tanash H, Rodríguez-García C, López-Campos JL, et al. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry. European Respiratory Journal. 2023;61(3):2201949. doi:10.1183/13993003.01949-2022

BibTeX
@article{Miravitlles2023,
  author = {Miravitlles, Marc and Turner, Alice M and Torres-Duran, María and Tanash, Hanan and Rodríguez-García, Carlota and López-Campos, José Luis and Chlumsky, Jan and Guimaraes, Catarina and Rodríguez-Hermosa, Juan Luis and Corsico, Angelo and Martinez-González, Cristina and Hernández-Pérez, José María and Bustamante, Ana and Parr, David G and Casas-Maldonado, Francisco and Hecimovic, Ana and Janssens, Wim and Lara, Beatriz and Barrecheguren, Miriam and González, Cruz and Stolk, Jan and Esquinas, Cristina and Clarenbach, Christian F and EARCO study investigators, EARCO study investigators},
  title = {Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry},
  journal = {European Respiratory Journal},
  year = {2023},
  volume = {61},
  number = {3},
  pages = {2201949},
  doi = {10.1183/13993003.01949-2022}
}
Kostenlos starten →